.png){kind=icon}
.png){kind=icon}
返回
Use of rituximab to decrease panel-reactive antibodies
.png){kind=icon}
PRE
AI
DOI：10.1016/j.healun.2004.01.006.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Patients with pre-formed antibodies may be at increased risk of rejection after organ transplantation. In this report, we describe the use of rituximab to decrease the percentage of pre-formed antibodies in a pediatric heart transplant recipient. Copyright (c) 2005 by the International Society for Heart and Lung Transplantation.
Keyword:
MYCOPHENOLATE-MOFETIL
MONOCLONAL-ANTIBODY
REJECTION
TRANSPLANTATION
SUPPRESSION
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。